Abstract
Granulocyte-colony stimulating factor (G-CSF) is commonly used in bone marrow transplant donors to increase the number of circulating progenitor cells. G-CSF has also been studied following myocardial infarction, but concern has been raised about the risks of G-CSF administration in patients with coronary artery disease. We present two cases of ischemic cardiac complications that are likely to be related to administration of G-CSF and provide a contemporary overview of the literature on the cardiovascular risks of G-CSF.
Original language | English (US) |
---|---|
Pages (from-to) | 98-101 |
Number of pages | 4 |
Journal | Catheterization and Cardiovascular Interventions |
Volume | 76 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1 2010 |
Keywords
- Coronary artery disease
- Filgrastim/adverse effects
- Inflammation
- Myocardial infarction